Nykode
About:
Nykode Therapeutics is a clinical-stage biopharmaceutical platform that develops novel vaccines against HPV-induced malignacies
Website: http://vaccibody.com
Top Investors: Norwegian Research Council, Kreftforeningen
Description:
Nykode Therapeutics is a clinical-stage biopharmaceutical platform that develops technology for novel vaccines and immunotherapy against HPV-induced malignancies.
Total Funding Amount:
31.7M EUR
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
Oslo, Oslo, Norway
Founded Date:
2007-01-01
Contact Email:
info(AT)vaccibody.com
Founders:
Martin Bonde
Number of Employees:
101-250
Last Funding Date:
2016-12-16
IPO Status:
Public
Industries:
© 2025 bioDAO.ai